Navigation Links
Half of U.S. Adults Lack 20/20 Vision
Date:8/11/2008

Distance problems, astigmatism becoming more common, study finds

MONDAY, Aug. 11 (HealthDay News) -- About half of all American adults don't have the 20/20 vision physicians consider optimal because they are nearsighted, farsighted, or have an irregular corneal curve known as astigmatism, a large, new study reports.

The study revealed that such common eye-focus problems -- collectively known as "refractive errors"-- affect young, middle-aged and older adults of all races. Corrective care for such problems amounts to an estimated $3.8 billion to $7.2 billion annually, the researchers said.

"I think this study demonstrates that the problem of refractive eyesight errors is on the increase, particularly in terms of the amount of nearsightedness in the American population," said study co-author Dr. Frederick L. Ferris III, clinical director of the U.S. National Eye Institute.

"This is probably a worldwide problem," he added. "No one knows for sure what accounts for this. But it's a pretty smart hypothesis that the increased amount of near work that we're doing as a population may be increasing the incidence of nearsightedness. And it does suggest that we should be looking into ways to deal with it."

Rando Allikmets, a professor of ophthalmology, pathology and cell biology at Columbia University, said, "I would hazard to suggest that, in general, the widespread prevalence of refractive issues today could be related to environmental factors, like extensive use of TV and computers, and -- among the young -- video games. Because today we get much heavier loads on our eyes from all of that, and those are strenuous activities for our vision."

To take a current snapshot of American eye health, the study authors, led by Susan Vitale of the U.S. National Eye Institute, analyzed data collected by the U.S. Centers for Disease Control and Prevention's ongoing National Health and Nutrition Examination Survey. Th
'/>"/>

Copyright©2008 ScoutNews,LLC.
All rights reserved

Page: 1 2 3

Related medicine news :

1. When it comes to abstinence teens, adults arent speaking the same language
2. KLRI Receives Grant From NIH to Study Stress Resilience in Older Adults
3. Risk of unintentional injury death is high for young children living with unrelated adults
4. Todobebes New Family TV Show Debuts as #1 Show in the U.S. Among All Adults 18 to 34
5. Protein made by fat cells may increase risk of heart attack in older adults
6. Most generalists reluctant to provide primary care for young adults with chronic illness
7. Magnetic Pulses to Brain Improve Lazy Eye in Adults
8. The benefits of a little resistance for older adults
9. For Young Adults, Borderline High Blood Pressure a Threat
10. Age-old money matters: Positivity in older adults leads to balanced investments
11. Do Underweight Newborns Make for Shy Adults?

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2009)...ds rising incidence of obesity could counter recen...Dec. 2 (HealthDay News) -- The overall health of t...e decades, largely because people have quit smokin...might soon be wiped out if the rising obesity rate... current trends in both smoking and obesity contin...
(Date:12/2/2009)..., PASADENA, Calif., Dec. 2 /PRNewswire-USNewswire/...has received the Gold Seal of Approval from the Jo... stroke center. This means Huntington will join t...hroughout Los Angeles County. ,, "This is a s...portant, a wonderful benefit for Pasadena and its ...
(Date:12/2/2009)..., MONTREAL, Dec. 2 /PRNewswire/ - As part of its ... world, Wyeth, now a part of Pfizer, has pledged m...actor concentrates to the World Federation of Hemo...de to the WFH,s Humanitarian Aid Program, and will...als. ,, "This donation will directly support bu...
(Date:12/2/2009)...ENA, Calif.Researchers from the California Institu...in detail, and for the first time, the previously ...in called ubiquitin are added by enzymes called ub...cycle. Ubiquitin chains tag target proteins for de...ll. , "We found that ubiquitin ligases build ubi...
(Date:12/2/2009)... National Pen ( www.pens.com ), a ...nnounced today it is giving away 10,000 free busin...December 2, 2009 -- National Pen ( www.pens.com ),... announced today it is giving away 10,000 free bus...y to promote business that no other company in the...
Breaking Medicine News(10 mins):Health News:Health Gains From Lowered Smoking Rates in Jeopardy 2Health News:Health Gains From Lowered Smoking Rates in Jeopardy 3Health News:Huntington Hospital Earns Designation as Primary Stroke Center 2Health News:The WFH receives the largest humanitarian aid donation in its history - Donation represents more than 40 million international units to the WFH 2Health News:Caltech scientists show how ubiquitin chains are added to cell-cycle proteins 2Health News:Caltech scientists show how ubiquitin chains are added to cell-cycle proteins 3Health News:Caltech scientists show how ubiquitin chains are added to cell-cycle proteins 4Health News:National Pen Giving Away 10,000 Business Card Pens 2
...stries,Ltd. (Reuters: SUN.BO, Bloomberg: SUNP IN, ...o Barrie Levitt, M.D., Chairman of Taro Pharmaceut...garding Taro,s purported,termination of the May 18...our agreement. We remain,skeptical of Taro,s turna...
... can read and have good phonetic skills - the abil...s may still be poor spellers. In a paper publishe...ton and Marian Annett, at the School of Psychology...rried out in a cohort of children drawn from norma...
...ry Health, CROMWELL, Conn., May 29 Though many d...ions (UTIs) are the second most common type,of inf...llion doctor visits,each year. One-third of women ...ze the signs of a UTI in the first place.,In respo...
...es as Many Calories as,Hand-Held, INDIANAPOLIS, M..., are quickly becoming the most coveted gaming,sys...ese systems appear to,be helpful in encouraging yo...he studies presented today examined energy expendi...
...rove in 83% of Patients S...FirstCall/ - Novadaq(R) Technologies Inc.,(TSX: ND...mage guidance,systems for the operating room, toda...R) System in commercial practice at the,recent Eur...
... study to be presented at America...y 29 The Montana Center for Work,Physiology and E...uman,clinical study at the Annual Meeting of the A...), had far fewer -- 23,percent -- upper respirator...
Other Medicine News:Health News:Sun Pharma Responds to Taro's Purported Termination of Merger Agreement 2Health News:Sun Pharma Responds to Taro's Purported Termination of Merger Agreement 3Health News:Sun Pharma Responds to Taro's Purported Termination of Merger Agreement 4Health News:Sun Pharma Responds to Taro's Purported Termination of Merger Agreement 5Health News:Sun Pharma Responds to Taro's Purported Termination of Merger Agreement 6Health News:Sun Pharma Responds to Taro's Purported Termination of Merger Agreement 7Health News:AZO Answers the Burning Question: What's Up Down There? 2Health News:AZO Answers the Burning Question: What's Up Down There? 3Health News:AZO Answers the Burning Question: What's Up Down There? 4Health News:Kids' Energy Expenditure High in Active Video Games 2Health News:Novadaq Updates on OPTTX Data Reported at Euroretina 2Health News:Novadaq Updates on OPTTX Data Reported at Euroretina 3Health News:Novadaq Updates on OPTTX Data Reported at Euroretina 4Health News:Montana Center for Work Physiology and Exercise Metabolism Presents Firefighter Health Study 2
(Date:12/2/2009)...sreal, December 2 Cardio...g developer of advanced,cardiovascular surgery tec...of Directors approved a one-for-three forward stoc...to Cardio Vascular Medical Device shareholders. ,...he estimated date the stock,split will be payable ...
(Date:12/2/2009)...., Dec. 2 Roche (SIX: RO...ed States Food & Drug Administration (FDA) app...nucleic acid test, to screen source plasma in pool...test, called the cobas® TaqScreen MPX Test fo...e, in-vitro test for the simultaneous, direct dete...
(Date:12/2/2009)...VER, N.J., Dec. 2 Novartis announc...presentation on Tasigna® (nilotinib) 200 mg c...onstrate the strength of the company,s hematology ..., The new data, at the 51st American Society of He...light the company,s current therapies and investig...
Breaking Medicine Technology:Cardio Vascular Medical Device Announces Forward Stock Split 2FDA Approves Use of Roche Test to Screen Source Plasma for HIV, Hepatitis B Virus and Hepatitis C Virus 2FDA Approves Use of Roche Test to Screen Source Plasma for HIV, Hepatitis B Virus and Hepatitis C Virus 3Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 2Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 3Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 4Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 5Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 6Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 7Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 8Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 9Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 10Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 11Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 12Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 13Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 14Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 15Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 16Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 17Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 18Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 19Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 20Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 21Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 22Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 23Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 24Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 25Advance in bowel cancer test research 48298 1Discovery raises new doubts about dinosaur bird links 8763 1Discovery raises new doubts about dinosaur bird links 8763 2Discovery raises new doubts about dinosaur bird links 8763 3Morphotek 28R 29 Inc Announces FDA Acceptance of Investigational New Drug Application for MORAb 004 a Monoclonal Antibody for the Treatment of Soli 48291 1Morphotek 28R 29 Inc Announces FDA Acceptance of Investigational New Drug Application for MORAb 004 a Monoclonal Antibody for the Treatment of Soli 48291 2Morphotek 28R 29 Inc Announces FDA Acceptance of Investigational New Drug Application for MORAb 004 a Monoclonal Antibody for the Treatment of Soli 48291 3
... WIRE)--Apr 23, 2007 - Aeolus,Pharmaceuticals, Inc...by researchers at Loma Linda University Medical Ce...hyrin antioxidants, AEOL,10113, may play an import...y ionizing radiation., Radiation therapy is used a...py in the care and management of nearly all adult ...
...eight loss medication Xenical,(orlistat 120mg) sig...lar risk factors such as blood pressure, glycaemic... people with type,2 diabetes and hypertension, acc...an Congress on Obesity (ECO), Budapest,Hungary.(1...already established,for Xenical that demonstrates ...
Other Medicine Technology:Aeolus Pharmaceuticals' AEOL 10113 May Play an Important Role,Regulating the Oxidative Damage Induced by Ionizing Radiation 2Aeolus Pharmaceuticals' AEOL 10113 May Play an Important Role,Regulating the Oxidative Damage Induced by Ionizing Radiation 3New Data Show Xenical Significantly Reduces Cardiovascular Risk and,More Than Doubles Weight Loss Achieved in Overweight and Obese,People 2New Data Show Xenical Significantly Reduces Cardiovascular Risk and,More Than Doubles Weight Loss Achieved in Overweight and Obese,People 3New Data Show Xenical Significantly Reduces Cardiovascular Risk and,More Than Doubles Weight Loss Achieved in Overweight and Obese,People 4New Data Show Xenical Significantly Reduces Cardiovascular Risk and,More Than Doubles Weight Loss Achieved in Overweight and Obese,People 5New Data Show Xenical Significantly Reduces Cardiovascular Risk and,More Than Doubles Weight Loss Achieved in Overweight and Obese,People 6
Wire Driver, Cannulated
Micro Saggital Saw
SmartDriver
Large Power Battery/Electric Reciprocating Saw
Medicine Products: